OBJECTIVE: To explore the previously reported associations between cervical squamous lesions and psychologic measures of stress and depression. METHODS: In a multicenter cohort study, women with HIV and HIV-seronegative women had Pap tests and completed self-report questionnaires including the Perceived Stress Scale-10 (PSS), which measures perceived stress, the Posttraumatic Stress Disorder (PTSD) Checklist-Civilian Version (PCL-C), which measures symptoms of PTSD, and the Center for Epidemiologic Studies Depression (CES-D) scale, which measures depressive symptoms. RESULTS: Median scores were 13 (range = 0-38) for the PSS, 24 (range = 17-85) for the PCL-C, and 8 (range = 0-57) for the CES-D, indicating moderate stress and minimal depression. For PSS, compared with women in the lowest tertile of reported stress, the odds ratios (ORs) for squamous intraepithelial lesions (SIL) were 0.88 (95% confidence interval [CI] = 0.50-1.54) for women in the middle tertile and 0.96 (95% CI = 0.54-1.68) for women in the highest tertile. For PCL-C, compared with women in the lowest tertile of PTSD symptoms, ORs for SIL were 0.79 (95% CI = 0.43-1.41) for women in the middle tertile and 1.17 (95% CI = 0.68-2.01) for women in the highest tertile. Rates of SIL were similar for CES-D scores 16 or higher (compared with women with lower scores; OR = 1.41, 95% CI = 0.88-2.26) and 23 or higher (OR = 1.39, 95% CI = 0.81-2.40). In the multivariable analysis including the number of sexual partners, age, income, ethnicity, and serostatus, stress as measured by PSS and PCL-C and depressive symptoms as measured by CES-D remained unassociated with SIL. CONCLUSIONS: We found no evidence that stress and depression affect the prevalence of cervical squamous lesions.
OBJECTIVE: To explore the previously reported associations between cervical squamous lesions and psychologic measures of stress and depression. METHODS: In a multicenter cohort study, women with HIV and HIV-seronegative women had Pap tests and completed self-report questionnaires including the Perceived Stress Scale-10 (PSS), which measures perceived stress, the Posttraumatic Stress Disorder (PTSD) Checklist-Civilian Version (PCL-C), which measures symptoms of PTSD, and the Center for Epidemiologic Studies Depression (CES-D) scale, which measures depressive symptoms. RESULTS: Median scores were 13 (range = 0-38) for the PSS, 24 (range = 17-85) for the PCL-C, and 8 (range = 0-57) for the CES-D, indicating moderate stress and minimal depression. For PSS, compared with women in the lowest tertile of reported stress, the odds ratios (ORs) for squamous intraepithelial lesions (SIL) were 0.88 (95% confidence interval [CI] = 0.50-1.54) for women in the middle tertile and 0.96 (95% CI = 0.54-1.68) for women in the highest tertile. For PCL-C, compared with women in the lowest tertile of PTSD symptoms, ORs for SIL were 0.79 (95% CI = 0.43-1.41) for women in the middle tertile and 1.17 (95% CI = 0.68-2.01) for women in the highest tertile. Rates of SIL were similar for CES-D scores 16 or higher (compared with women with lower scores; OR = 1.41, 95% CI = 0.88-2.26) and 23 or higher (OR = 1.39, 95% CI = 0.81-2.40). In the multivariable analysis including the number of sexual partners, age, income, ethnicity, and serostatus, stress as measured by PSS and PCL-C and depressive symptoms as measured by CES-D remained unassociated with SIL. CONCLUSIONS: We found no evidence that stress and depression affect the prevalence of cervical squamous lesions.
Authors: Michael H Antoni; Deidre B Pereira; Ilona Marion; Nicole Ennis; Michele Peake Andrasik; Rachel Rose; Judith McCalla; Trudi Simon; Mary Ann Fletcher; Joseph Lucci; Jonell Efantis-Potter; Mary Jo O'Sullivan Journal: J Psychosom Res Date: 2008-10 Impact factor: 3.006
Authors: H Minkoff; L Ahdieh; L S Massad; K Anastos; D H Watts; S Melnick; L Muderspach; R Burk; J Palefsky Journal: AIDS Date: 2001-11-09 Impact factor: 4.177
Authors: Richard E Nettles; Tara L Keiffer; Joseph Cofrancesco; Joel E Gallant; Thomas Quinn; Brooks Jackson; Charles Flexner; Kathryn A Carson; Albert W Wu; Robert F Siliciano Journal: HIV Clin Trials Date: 2005 Sep-Oct
Authors: Tonja R Nansel; Margaret A Riggs; Kai-Fun Yu; William W Andrews; Jane R Schwebke; Mark A Klebanoff Journal: Am J Obstet Gynecol Date: 2006-02 Impact factor: 8.661
Authors: L S Massad; L Ahdieh; L Benning; H Minkoff; R M Greenblatt; H Watts; P Miotti; K Anastos; M Moxley; L I Muderspach; S Melnick Journal: J Acquir Immune Defic Syndr Date: 2001-08-15 Impact factor: 3.731
Authors: Deidre Byrnes Pereira; Michael H Antoni; Aimee Danielson; Trudi Simon; JoNell Efantis-Potter; Charles S Carver; Ron E F Durán; Gail Ironson; Nancy Klimas; Mary Ann Fletcher; Mary Jo O'Sullivan Journal: J Psychosom Res Date: 2003-03 Impact factor: 3.006
Authors: Carolyn Y Fang; Suzanne M Miller; Dana H Bovbjerg; Cynthia Bergman; Mitchell I Edelson; Norman G Rosenblum; Betsy A Bove; Andrew K Godwin; Donald E Campbell; Steven D Douglas Journal: Ann Behav Med Date: 2008-02-13
Authors: Leah H Rubin; Judith A Cook; Kathleen M Weber; Mardge H Cohen; Eileen Martin; Victor Valcour; Joel Milam; Kathryn Anastos; Mary A Young; Christine Alden; Deborah R Gustafson; Pauline M Maki Journal: J Neurovirol Date: 2015-03-20 Impact factor: 2.643
Authors: L Stewart Massad; Kathleen M Weber; Tracey E Wilson; Johanna L Goderre; Nancy A Hessol; Donna Henry; Christine Colie; Howard D Strickler; Alexandra M Levine; D Heather Watts; Charlesnika T Evans Journal: J Low Genit Tract Dis Date: 2012-04 Impact factor: 1.925
Authors: Tonya N Taylor; Jeremy Weedon; Elizabeth T Golub; Stephen E Karpiak; Monica Gandhi; Mardge H Cohen; Alexandra M Levine; Howard L Minkoff; Adebola A Adedimeji; Lakshmi Goparaju; Susan Holman; Tracey E Wilson Journal: AIDS Behav Date: 2015-05